Saturday Jul 19, 2025
NEWSLETTER
www.israelhayom.com
  • Home
  • News
    • Israel
    • Israel at War
    • Middle East
    • United States
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • News
    • Israel
    • Israel at War
    • Middle East
    • United States
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home Science & Technology

Bayer to invest in Israeli biotech incubator FutuRx

Pharmaceutical giant's impact investment unit Leap partners with leading Israeli biotechnology incubator focused on innovative therapeutic technologies with the aim of pioneering scientific breakthroughs.

by  ILH Staff
Published on  07-28-2020 14:05
Last modified: 07-28-2020 22:36
Bayer to invest in Israeli biotech incubator FutuRxGetty Images

“FutuRx and Leaps by Bayer share the objective to invest in scientific breakthroughs," incubator says | Illustration: Getty Images

Share on FacebookShare on Twitter

Biotech incubator FutuRx announced Tuesday that Leaps, the impact investment unit of pharmaceutical giant Bayer AG, will join it as an investor for incepting and incubating early-stage biotech companies.

Both Leaps by Bayer and FutuRx invest in paradigm-shifting technologies in the life sciences, aiming to change the world for the better.

 Follow Israel Hayom on Facebook and Twitter

FutuRx is the leading Israeli biotechnology incubator focused on innovative, early-stage therapeutic technologies, which has established 20 companies to date with longstanding investors Johnson & Johnson Innovation, Takeda Ventures, and OrbiMed Israel Partners. FutuRx also enjoys the backing of the Israeli Innovation Authority.

Leaps by Bayer leads impact investments into solutions to some of today's biggest challenges in health and agriculture.

Its portfolio includes more than 30 companies, all of which focus on potentially breakthrough technologies to overcome specific challenges, such as regenerating lost tissue function, reducing the environmental impact of farming, preventing or curing cancer, and others.

Leaps by Bayer's investment portfolio includes more than 30 companies (Courtesy)

"We are very excited to have Leaps by Bayer join our investor group," FutuRx's CEO Dr. Kinneret Savitzky said.

"FutuRx and Leaps by Bayer share the objective to invest in scientific breakthroughs and enable the translation to novel therapies or even cures. Our portfolio companies benefit from the knowledge and support of our multinational pharma and VC partners at every step of the way towards reaching meaningful inflection points, and we are thrilled to bring into play Bayer's unique expertise and capabilities in the many therapeutic areas in which it is active."

Leaps chief Dr. Juergen Eckhardt said, "Leaps by Bayer invests in paradigm-shifting advances in the life sciences and it's our mission to move the paradigm from treatment to cure. FutuRx offers a portfolio of diverse companies in terms of technologies and therapeutic areas, all focused in novel science and with the ability to overcome some of today's challenges in healthcare."

Leaps by Bayer said it will work closely with the incubator's management team and investors to support its incubated portfolio companies and will participate in seed investment rounds in the new companies to be incepted at FutuRx going forward.

"We are pleased to see an additional global Life Science company expand its Biopharma R&D exposure to the Israeli ecosystem and join our distinguished incubator program which through FutuRx has been a major catalyst of the Israeli Biotechnology ecosystem," said Anya Eldan, Head of the StartUP division at the Israel Innovation Authority.

"I am confident that Leaps' focus and experience with breakthrough biotechnologies will be an asset to FutuRx's work incepting new companies enabling Bio-Convergence, combining life sciences discoveries and cutting-edge technologies for the benefit of mankind."

Subscribe to Israel Hayom's daily newsletter and never miss our top stories!

Related Posts

NVIDIA chief's China trip signals tech thaw with USJade GAO / AFP

NVIDIA chief's China trip signals tech thaw with US

by Erez Linn

Jensen Huang, Nvidia’s chief executive officer, radiated optimism during his third China visit in six months, engaging reporters in Beijing’s...

The bug whisperer: Israeli scientists decode nature's hidden languageFreepik

The bug whisperer: Israeli scientists decode nature's hidden language

by Adi Nirman

A groundbreaking study from Tel Aviv University has provided the first scientific evidence of acoustic interaction between plants and insects.

Did Conor McGregor send nude photos to rapper?AP/John Locher

Did Conor McGregor send nude photos to rapper?

by Erez Linn

Azealia Banks shares alleged screenshots on social media platform.

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • News
    • Israel at War
    • Israel
    • United States
    • Middle East
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • News
    • Israel at War
    • Israel
    • United States
    • Middle East
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il